Estrogens, esterified | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Estrogens, Esterified
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

Gonane Estradiol

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Estrogens, esterified

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 11 USDMF, 10 CEP/COS, 2 JDMF, 2 EU WC, 10 KDMF, 31 NDC API, 4 VMF, 17 Listed Suppliers, $ API Reference Price

30 API Suppliers
11 USDMF
10 CEP/COS
2 JDMF
2 EU WC
10 KDMF
31 NDC API
4 VMF
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

534 FDF Dossiers, 223 FDA Orange Book, 222 Europe, 29 Canada, 23 Australia, 27 South Africa, 10 Listed Dossiers

534 FDF Dossiers
223 FDA Orange Book
222 Europe
29 Canada
23 Australia
27 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR, INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR, SYSTEM;TRANSDERMAL - 0.025MG/24HR, SYSTEM;TRANSDERMAL - 0.0375MG/24HR, SYSTEM;TRANSDERMAL - 0.05MG/24HR, SYSTEM;TRANSDERMAL - 0.075MG/24HR, SYSTEM;TRANSDERMAL - 0.1MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;VAGINAL - 10MCG, TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 0.5MG;100MG, CAPSULE;ORAL - 1MG;100MG, GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION), FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR, TABLET;ORAL - 0.25MG;0.5MG, TABLET;ORAL - 0.5MG;1MG, GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION), SPRAY;TRANSDERMAL - 1.53MG/SPRAY, GEL;TRANSDERMAL - 0.1% (0.25GM/PACKET), GEL;TRANSDERMAL - 0.1% (0.5GM/PACKET), GEL;TRANSDERMAL - 0.1% (0.75GM/PACKET), GEL;TRANSDERMAL - 0.1% (1.25GM/PACKET), GEL;TRANSDERMAL - 0.1% (1GM/PACKET), CREAM;VAGINAL - 0.01%

FILM, EXTENDED RELEASE;TRANSDERMAL - 0.025MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.0375MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.06MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.075MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/24HR
INSERT, EXTENDED RELEASE;VAGINAL - 0.0075MG/24HR
SYSTEM;TRANSDERMAL - 0.025MG/24HR
SYSTEM;TRANSDERMAL - 0.0375MG/24HR
SYSTEM;TRANSDERMAL - 0.05MG/24HR
SYSTEM;TRANSDERMAL - 0.075MG/24HR
SYSTEM;TRANSDERMAL - 0.1MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;VAGINAL - 10MCG
TABLET;VAGINAL - 25MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 0.5MG;100MG
CAPSULE;ORAL - 1MG;100MG
GEL, METERED;TRANSDERMAL - 0.06% (1.25GM/ACTIVATION)
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.045MG/24HR;0.015MG/24HR
TABLET;ORAL - 0.25MG;0.5MG
TABLET;ORAL - 0.5MG;1MG
GEL, METERED;TRANSDERMAL - 0.06% (0.87GM/ACTIVATION)
SPRAY;TRANSDERMAL - 1.53MG/SPRAY
GEL;TRANSDERMAL - 0.1% (0.25GM/PACKET)
GEL;TRANSDERMAL - 0.1% (0.5GM/PACKET)
GEL;TRANSDERMAL - 0.1% (0.75GM/PACKET)
GEL;TRANSDERMAL - 0.1% (1.25GM/PACKET)
GEL;TRANSDERMAL - 0.1% (1GM/PACKET)
CREAM;VAGINAL - 0.01%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 8 SPI Pharma, 2 Seqens, 10 DKSH, 2 Jai Radhe Sales, 6 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 33 BASF, 1 BioSpectra, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 16 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

93 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 46 Direct Compression, 35 Controlled & Modified Release, 34 Disintegrants & Superdisintegrants, 34 Solubilizers, 32 Thickeners and Stabilizers, 31 Granulation, 31 Topical, 24 Film Formers & Plasticizers, 23 Parenteral, 22 Lubricants & Glidants, 21 Co-Processed Excipients, 17 Taste Masking, 15 Emulsifying Agents, 9 API Stability Enhancers, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

93 Fillers, Diluents & Binders
60 Coating Systems & Additives
46 Direct Compression
35 Controlled & Modified Release
34 Disintegrants & Superdisintegrants
34 Solubilizers
32 Thickeners and Stabilizers
31 Granulation
31 Topical
24 Film Formers & Plasticizers
23 Parenteral
22 Lubricants & Glidants
21 Co-Processed Excipients
17 Taste Masking
15 Emulsifying Agents
9 API Stability Enhancers
9 Empty Capsules
8 Chewable & Orodispersible Aids
7 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 41 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
41 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 126 Finished Drug Prices, 7 Annual Reports

1 US Medicaid Prescriptions
126 Finished Drug Prices
7 Annual Reports

MARKET PLACE

10 APIs, 3 FDF Dossiers

10 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

131 US Patents, 6 US Exclusivities

131 US Patents
6 US Exclusivities

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 Others

4 EDQM
3 USP
4 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,513 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 1GE HEALTHCARE

02 1SOLARIS PHARMA CORP

03 4SUMITOMO PHARMA

filter Product Reset all filters

6 All

01 1ESTRADIOL

02 4ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

03 1FLUOROESTRADIOL F-18

filter Exclusivity Expiration Date Reset all filters

6 All

01 12024-05-26

02 12024-10-23

03 12025-05-20

04 12025-08-05

05 12025-12-18

06 12026-01-27

filter Exclusivity Code Reset all filters

6 All

01 1CGT

02 1I-898

03 1M-289

04 2NCE

05 1NP

Symbiotec Estradiol

Product Main Page

SUMITOMO PHARMA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2024-05-26

Application Number

214846

Product Number

1

Exclusivity Details

01

SUMITOMO PHARMA

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Pharmtech & Ingredients

Not Confirmed

SUMITOMO PHARMA

Japan

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-05-26

Application Number : 214846

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SUMITOMO PHARMA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2025-12-18

Application Number

214846

Product Number

1

Exclusivity Details

02

SUMITOMO PHARMA

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Pharmtech & Ingredients

Not Confirmed

SUMITOMO PHARMA

Japan

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Exclusivity Code : NCE

Exclusivity Expiration Date : 2025-12-18

Application Number : 214846

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SOLARIS PHARMA CORP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ESTRADIOL

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

CGT

Exclusivity Expiration Date

2024-10-23

Application Number

216160

Product Number

1

Exclusivity Details

03

SOLARIS PHARMA CORP

Pharmtech & Ingredients

Not Confirmed

SOLARIS PHARMA CORP

U.S.A

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : CGT

Exclusivity Expiration Date : 2024-10-23

Application Number : 216160

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GE HEALTHCARE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FLUOROESTRADIOL F-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2025-05-20

Application Number

212155

Product Number

1

Exclusivity Details

04

GE HEALTHCARE

FLUOROESTRADIOL F-18

Pharmtech & Ingredients

Not Confirmed

GE HEALTHCARE

United Kingdom

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FLUOROESTRADIOL F-18

Exclusivity Code : NCE

Exclusivity Expiration Date : 2025-05-20

Application Number : 212155

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SUMITOMO PHARMA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-898

Exclusivity Expiration Date

2025-08-05

Application Number

214846

Product Number

1

Exclusivity Details

05

SUMITOMO PHARMA

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Pharmtech & Ingredients

Not Confirmed

SUMITOMO PHARMA

Japan

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Exclusivity Code : I-898

Exclusivity Expiration Date : 2025-08-05

Application Number : 214846

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SUMITOMO PHARMA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-289

Exclusivity Expiration Date

2026-01-27

Application Number

214846

Product Number

1

Exclusivity Details

06

SUMITOMO PHARMA

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Pharmtech & Ingredients

Not Confirmed

SUMITOMO PHARMA

Japan

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX

Exclusivity Code : M-289

Exclusivity Expiration Date : 2026-01-27

Application Number : 214846

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?